T

Tabula Rasa HealthCare Inc
F:43T

Watchlist Manager
Tabula Rasa HealthCare Inc
F:43T
Watchlist
Price: 9.6 EUR Market Closed
Market Cap: €260.4m

Tabula Rasa HealthCare Inc
Investor Relations

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. The company is headquartered in Moorestown, New Jersey and currently employs 1,602 full-time employees. The company went IPO on 2016-09-29. The Company’s segments include CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. The company accesses the market through a number of different service lines and brands, including CareKinesis, Capstone Risk Adjustment Services, CareVention Consulting, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides its clients, primarily health plans, and retail pharmacies. The company provides cloud-based patient engagement software and services and full-service clinical pharmacy programs. The company provides medication therapy management (MTM) software and services for Medicare, Medicaid, and commercial health plans.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2023
Call Date
May 9, 2023
Q1 2023 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Other Earnings Calls
2023

Management

Mr. Brian W. Adams
Interim CEO, Pres & Sec.
No Bio Available
Mr. Michael Greenhalgh
Chief Operating Officer
No Bio Available
Mr. Thomas J. Cancro C.F.A., CPA
Chief Financial Officer
No Bio Available
Ms. Andrea Carolan Speers M.S.
Corp. Controller & Chief Accounting Officer
No Bio Available
Mr. Bob Sullivan M.S.
Chief Technology Officer
No Bio Available
Dr. Jacques Turgeon B.Pharm., Ph.D.
Chief Scientific Officer & CEO of TRHC Precision Pharmacotherapy, R&D Institute
No Bio Available
Mr. Phillip W. Heath MS
Chief Admin. Officer
No Bio Available
Mr. Frank Sparacino C.F.A., CPA
Sr. VP of Investor Relations & Corp. Devel.
No Bio Available
Mr. Kevin J. Dill DMIN, J.D.
Gen. Counsel
No Bio Available
Ms. Kathleen D Larkin M.B.A.
Chief People Officer
No Bio Available

Contacts

Address
NEW JERSEY
Moorestown
228 Strawbridge Drive, Suite 100
Contacts